Baird raised the firm’s price target on Emerson (EMR) to $140 from $136 and keeps a Neutral rating on the shares. The firm said the business seems to be hitting stride at just the right time.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR: